Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2273-4309
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force ; volume:11 ; number:2 ; day:1 ; month:4 ; year:2022 ; pages:135-142 ; date:4.2022
The journal of Frailty & Aging ; 11, Heft 2 (1.4.2022), 135-142, 4.2022
- Creator
-
Cesari, Matteo
Bernabei, R.
Vellas, B.
Fielding, R. A.
Rooks, D.
Azzolino, D.
Mariani, J.
Oliva, A. A.
Bhasin, S.
Rolland, Y.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jfa.2022.30
- URN
-
urn:nbn:de:101:1-2022070221094200646193
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cesari, Matteo
- Bernabei, R.
- Vellas, B.
- Fielding, R. A.
- Rooks, D.
- Azzolino, D.
- Mariani, J.
- Oliva, A. A.
- Bhasin, S.
- Rolland, Y.
- SpringerLink (Online service)
Other Objects (12)
Sarcopenia and the syndrome of frailty
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Healthcare cost expenditures associated to frailty and sarcopenia
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database
Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review
Sarcopenia and the syndrome of frailty
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Healthcare cost expenditures associated to frailty and sarcopenia
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database
Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review
Sarcopenia and the syndrome of frailty
ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty
Healthcare cost expenditures associated to frailty and sarcopenia
Do Malnutrition, Sarcopenia and Frailty Overlap in Nursing-Home Residents?
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group
Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database